<div class="headers"><div>Figure 5 Change in mean sitting systolic blood pressure (MSSBP) (mm Hg) from baseline to week 8 by treatment strategy and selected subgroups in black patients with stage 2 hypertension BMI ¼ body mass index; CI ¼ confidence interval; ISH ¼ isolated systolic hypertension. N is the number of intent-to-treat patients of the respective subgroup.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; border-bottom: 2px solid grey; text-align: left;'><p class="">Figure 5 Change in mean sitting systolic blood pressure (MSSBP) (mm Hg) from baseline to week 8 by treatment strategy and selected subgroups in black patients with stage 2 hypertension BMI ¼ body mass index; CI ¼ confidence interval; ISH ¼ isolated systolic hypertension. N is the number of intent-to-treat patients of the respective subgroup.</p></td>
</tr>
</tbody>
</table>
